Neural stem cells aplenty Export

@article{citeulike:4226278, abstract = {Sloan-Kettering researchers have developed a neural induction protocol that could increase the commercial viability of therapies and systems that require human neural stem cells through better speed and applicability in a GMP setting.}, author = {Lou, Kai-Jye}, citeulike-article-id = {4226278}, citeulike-linkout-0 = {http://dx.doi.org/10.1038/scibx.2009.476}, citeulike-linkout-1 = {http://www.nature.com/scibx/journal/v2/n12/index.html}, citeulike-linkout-2 = {http://www.nature.com/scibx/journal/v2/n12/full/scibx.2009.476.html}, day = {26}, doi = {10.1038/scibx.2009.476}, issn = {1945-3477}, journal = {Science-Business eXchange}, keywords = {regen\_neuro, scibx\_regen}, month = {March}, number = {12}, pages = {1--2}, posted-at = {2009-03-26 22:40:37}, priority = {2}, title = {Neural stem cells aplenty}, url = {http://dx.doi.org/10.1038/scibx.2009.476}, volume = {2}, year = {2009} }

TY - JOUR ID - citeulike:4226278 L3 - citeulike-article-id:4226278 N2 - Sloan-Kettering researchers have developed a neural induction protocol that could increase the commercial viability of therapies and systems that require human neural stem cells through better speed and applicability in a GMP setting. IS - 12 JF - Science-Business eXchange SN - 1945-3477 EP - 2 TI - Neural stem cells aplenty VL - 2 SP - 1 KW - regen_neuro KW - scibx_regen AU - Lou, Kai-Jye PY - 2009/03/26/ UR - http://dx.doi.org/10.1038/scibx.2009.476 ER -